Philip L. Molyneaux - Concepedia

Author

Philip L. Molyneaux

Also Known As

A. Platt, Ann B Millar, Brian L Yaspan, Chloe Mears, DA Schwartz, Footitt, Joseph, G Jenkins, H E Hardwick, J Jacob, J Mitchell

436

Publications

14.8K

Citations

H-Index

118

Concepts

All Affiliations

Imperial College London Royal Brompton Hospital Guy's and St Thomas' NHS Foundation Trust University of Southern California University College London

About

Philip L. Molyneaux is an author at Imperial College London specializing in medicine, pulmonary disease, and pulmonary medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	28	2.4K
2	Public Health	8	8	327
3	Health Sciences	3	3	119
4	Engineering	1	1	48
5	Social Sciences	1	1	12

Philip L. Molyneaux

107

Publications

10.2K

Citations

H-Index

Page 1

	Year	Citations
The Role of Bacteria in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis Philip L. Molyneaux, Michael J. Cox, Saffron A.G. Willis‐Owen, American Journal of Respiratory and Critical Care Medicine	2014	540
Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment Katherine Myall, Bhashkar Mukherjee, Ana Margarida Castanheira, Annals of the American Thoracic Society	2021	426
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study Rachael A Evans, Olivia C. Leavy, Matthew Richardson, The Lancet Respiratory Medicine	2022	407
Outgrowth of the Bacterial Airway Microbiome after Rhinovirus Exacerbation of Chronic Obstructive Pulmonary Disease Philip L. Molyneaux, Patrick Mallia, Michael J. Cox, American Journal of Respiratory and Critical Care Medicine	2013	397
PD-1 up-regulation on CD4 <sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production Lindsay J. Celada, Jonathan A. Kropski, Jose D. Herazo‐Maya, Science Translational Medicine	2018	354
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities Peter M. George, Paolo Spagnolo, Michael Kreuter, The Lancet Respiratory Medicine Research PrioritiesAntifibrotic TherapyFibrosisPulmonary PathologyAdvanced Lung Disease	2020	332
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis Richard J. Allen, Beatriz Guillén‐Guío, Justin M. Oldham, American Journal of Respiratory and Critical Care Medicine	2019	323
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study Gísli Jenkins, Juliet K. Simpson, Gauri Saini, The Lancet Respiratory Medicine FibrosisAdvanced Lung DiseasePathologyBiomarkersPulmonary Fibrosis	2015	316
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study Richard J. Allen, Joanne Porte, Rebecca Braybrooke, The Lancet Respiratory Medicine	2017	294
An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study Toby M. Maher, Eunice Oballa, Juliet K. Simpson, The Lancet Respiratory Medicine InflammationFibrosisIdiopathic Pulmonary FibrosisPulmonary Alveolar ProteinosisBiomarkers	2017	262

Page 1